Clinical Trial Update: TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment [Phase 2]

View source ↗

Summary

Phase 2 TB trial TBTC Study 28 comparing moxifloxacin with isoniazid for tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)
• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED